News CSPC Pharmaceutical Group Limited

Stocks

1093

HK1093012172

Pharmaceuticals

Market Closed - Hong Kong S.E. 04:08:09 2026-10-23 EDT			5-day change	1st Jan Change
8.345 ^HKD	-0.12%		-6.02%	-1.01%

10-23	CSPC Pharma's Injection for Rare Autoimmune Disease Gets Regulatory Nod in China	MT
10-22	Pharma sector doubles down on AI to slash costs, timelines	RE

All News

Mentions Relevance

10-23	CSPC Pharma's Injection for Rare Autoimmune Disease Gets Regulatory Nod in China	MT
10-20	CSPC Pharma Begins Trial of Dry Eye Disease Drops	MT
10-20	CSPC Pharmaceutical Group Limited Initiates Phase I Clinical Trial Of SYH2083 Eye Drops For The Treatment Of Dry Eye Disease In China	CI
10-15	CSPC Pharma Gets China Nod for Tumor Drug Trial	MT
10-15	CSPC Pharmaceutical Group Limited Obtains Clinical Trial Approval For SYS6088 Injection In China	CI
10-15	CSPC Pharmaceutical Group Limited Obtains Clinical Trial Approval For SYS6062 In China	CI
10-08	CSPC Pharma Presents Data from Cervical Cancer Study at Gynecologic Cancer Society Meeting	MT
10-08	CSPC Pharmaceutical Group Limited Presents Data From Phase I Clinical Study Of SYS6002 As Monotherapy For The Treatment Of Advanced Cervical Cancer At IGCS2026	CI
10-05	CSPC Pharma to Present Updates from Eight Trials at European Oncology Conference	MT
10-01	CSPC Reports Blood Sugar Reduction in Phase III Diabetes Study	MT
09-30	CSPC Pharmaceutical Group Limited Presents Results of Phase III Clinical Study of Efmedaglutide Alfa Injection in Combination with Metformin in Chinese Adult Patients with Type 2 Diabetes Mellitus	CI
09-29	CSPC Pharma Gets US FDA Approval to Start Herpes Zoster Vaccine Trial	MT
09-29	CSPC Pharma Begins Phase 1b Trial of Weight Management Drug in China	MT
09-29	CSPC Pharmaceutical Group Limited Initiates Phase IB Clinical Trial Of JMT206 Injection For Weight Management In Adult Patients With Overweight Or Obesity At The First Study Centre In China	CI
09-29	CSPC Pharmaceutical Group Limited Obtains U.S. Clinical Trial Approval For Recombinant Herpes Zoster Vaccine	CI
09-28	CSPC Pharma Gets China Nod for Tumor Drug Trial	MT
09-28	CSPC Pharmaceutical Group Limited Obtains Clinical Trial Approval For SYS6077 Injection In China	CI
09-24	CSPC Pharmaceutical Group Limited Initiates Phase III Clinical Trial Of Docetaxel For Injection (Albumin-Bound) For Treatment Of Advanced Breast Cancer In China	CI
09-24	CSPC Pharmaceutical Group Limited Announces Phase III Clinical Trial Of Becotatug In Combination With Osimertinib Achieves Positive Topline Results	CI
09-24	CSPC Pharma's Phase III Trial of Lung Cancer Drug Combo Achieves Positive Topline Results	MT
09-24	CSPC Pharm Begins Phase III Breast Cancer Drug Trial	MT
09-21	US Considers Rules Allowing American Investment in Chinese Drugs	MT
09-16	CSPC Pharmaceutical Group Limited Initiates Phase II Clinical Trial Of SYH2069 Injection For Treatment Of Type 2 Diabetes Mellitus In Adult Patients At First Centre In China	CI
09-16	CSPC Pharma Begins Diabetes Drug Trial in China	MT
09-15	CSPC Pharmaceutical Gets Breakthrough Therapy Designation for Lung Cancer Drug	MT